Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Brighton Jones LLC Increases Stake in Vertex Pharmaceuticals VRTX

January 29, 2025
Brighton Jones LLC, a prominent investment firm, has recently revealed that it has increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). This move showcases the firm's confidence in the future prospects of Vertex Pharmaceuticals. With their expertise in the field, it is recommended to consider their stance while making investment decisions. For a more detailed prognosis on the movement of Vertex Pharmaceuticals' stock, it is advisable to consult professionals from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for VRTX

Related data

VRTXAugust 15, 2025Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) continues to make headlines as a leader in developing treatments for rare diseases....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Price Target, Generating 8.59% Profit  ~1 min.

On May 7, 2024, QuantWave issued a short signal for VERTEX PHARMACEUTICALS INCORPORATED with a price target of 374.98 $....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 15.82% Profit, Validates QuantWave's Forecasting Accuracy  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the price target forecast set by QuantWave, a notable milestone that not only indicates the platform's forecasting accuracy but also presents a lucrative opportunity for investors. The forecast signal was generated on June 2, 2025, when the stock was trading at $445.43, with a predicted short direction. Fast forward to August 5, 2025, th...


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecasted price target, as predicted by QuantWave's automated forecasting platform on 2025-06-03....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 8.54% Profit Margin  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved its price target forecast, generating an 8.54% profit margin for investors....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecast Target with 7.36% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully achieved the price target forecast set by QuantWave, a leading automated forecasting platform, with a profitable outcome of 7.36%....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Reaches Price Target Forecast with 8.02% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock successfully reached the price target forecast set by QuantWave on July 9, 2025....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Target with 8.37% Profit: A Success Story for QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecast price target set by QuantWave, resulting in a profit of 8.37% for investors who followed the long prediction signal....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Hits Forecasted Price Target with 8.64% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) stock successfully reached the forecasted price target set by QuantWave on 2025-06-20, with a predicted long direction. The stock was valued at 440....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....


VRTXJanuary 1, 2025Exciting Growth Predicted for Vertex Pharmaceuticals VRTX: Expert Analysis  ~1 min.

According to recent reports, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is predicted to experience significant growth in the near future....


VRTXJanuary 2, 2025Vertex Pharmaceuticals Incorporated: Promising Future Ahead  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is gaining attention in the options market, with predictions of a potential spike in its stock. Brokerages have set a price target of $494....


VRTXFebruary 12, 2025Vertex Pharmaceuticals Incorporated reports strong financial results for Q4 and full year 2024  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced its fourth quarter and full year 2024 financial results, exceeding expectations with record-breaking revenue of $11.02 billion....


VRTXFebruary 22, 2025Vertex Pharmaceuticals Incorporated to Participate in Upcoming Investor Conferences  ~2 min.

Rhumbline Advisers disclosed today its 178.14 million stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), making it a major shareholder in the company....


VRTXJanuary 9, 2025Central Pacific Bank Trust Division Has 2.08 Million Holdings in Vertex Pharmaceuticals Incorporated NASDAQ:VRTX  ~1 min.

Central Pacific Bank Trust Division recently announced that it has acquired a sizable stake in the renowned pharmaceutical company, Vertex Pharmaceuticals Incorporated....